Investment Column: Sportingbet is a gamble after Italian fiasco

Galiform; Sinclair Pharma


Our view: Sell

Share price: 56.25p (+1.25p)

There's nothing wrong with pulling the plug on an underperforming business, and in financial terms at least, Sportingbet's ignominious exit from Italy could be seen as a positive.

The operation managed to generate a pitiful £2m of net gaming revenue and lost £1.5m this year. Given that, it's perhaps no wonder the company is happily saying ciao to the business, even if the £7.1m exceptional loss it will have to report as a result does leave an ugly scar on the next set of numbers.

The company blames the failure of the business on product restrictions imposed by the Italian authorities, which reformed gambling regulation in a way that was not conducive to Sporting's model.

In effect, they called the market wrong, and the exit now raises some questions about Sporting's ability, as an offshore operator, to capitalise on and work within a liberalising, but still highly regulated, framework. Others may, after all, follow the Italian model, and to generate stable growth gambling companies really need to be prepared to accept the local restrictions in return for legal certainty in the territories in which they operate. Generally Sportingbet is doing ok, enjoying a good start to what is traditionally a quiet fourth quarter,. and unless the company settles its little problem with the US Department of Justice, things should be stable enough until October when full-year results are due to be reported.

Currently Sporting is priced at 10.4 times forecast full-year earnings. It is pretty good at bookmaking, but that is high enough given that it is an offshore operator with a high degree of regulatory risk whose earnings are not showing a great deal of growth. Collins Stewart notes that its top line has been flat for fully six quarters.

Given all this, those wanting exposure to the gambling industry should seek greener pastures. Sell.

Galiform

Our view: Buy

Share price: 46.5p (+9p)

Investors in Galiform, the group behind Howden kitchens that are sold directly to small builders, got a boost yesterday as the group published its first-half trading update.

The shares leapt 24 per cent as the group said that while sales were continuing to fall, they were doing so at a reduced rate. If the trend continues, the group would consider opening new depots in the autumn, it said.

That is good news indeed for shareholders, who have suffered somewhat from the company being association with MFI, a legacy that now includes just a handful of property guarantees.

This is also why the group trades at a discount to its peers, says the group.

Notwithstanding yesterday's share price jump, the discount is still significant, according to analysts at Numis, who argued before yesterday's update that "at the current share price Galiform trades at a 20 per cent plus discount to the merchanting peers on price earnings and enterprise value to Ebitda metrics (adjusting for the MFI legacy), which in our view is clearly illogical".

We agree that the group is a better bet than that and would still buy the stock, in spite of yesterday's price increases. Buy.

Sinclair Pharma

Our view: Cautious hold

Share price: 23.25p (-2.5p)

Sinclair Pharma, the speciality dermatology and oral healthcare group, issued its full-year trading statement yesterday, saying that Ebitda is up, and thanks to its "decisive and proactive steps to restructure and streamline the business," costs have been reduced, while the depth of management expertise has been increased.

Sadly, what it also mentions is that revenues disappointed – 15 per cent below analysts' consensus, say the experts at Piper Jaffray – sending the shares down 9.6 per cent.

The group blames "wholesaler de-stocking in the face of the economic downturn" for the drop in revenue, adding that the first data for 2010 suggests that sales are now returning to previous trends. While that is undoubtedly good news, the market is clearly waiting for more evidence, and we would suggest that investors consider taking profits from the last six months, which have seen the stock jump by more than 80 per cent, at this stage.

True, the Piper Jaffray watchers point to the group's "strong product portfolio", but argue that investors should be underweight on the shares, adding that the sales execution is disappointing and that they are "cautious on the outlook for the stock".

The group argues that significant product launches this year should help the stock, and we would give Sinclair the benefit of the doubt, for now. Cautious hold.

Start your day with The Independent, sign up for daily news emails
Arts and Entertainment
Lou Reed distorted the truth about his upbringing, and since his death in 2013, biographers and memoirists have added to the myths
musicThe truth about Lou Reed's upbringing beyond the biographers' and memoirists' myths
News
people
News
Ed Miliband received a warm welcome in Chester
election 2015
Life and Style
Apple CEO Tim Cook announces the Apple Watch during an Apple special even
fashionIs the Apple Watch for you? Well, it depends if you want it for the fitness tech, or for the style
ebooks
ebooksA special investigation by Andy McSmith
  • Get to the point
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

SThree: Trainee Recruitment Consultant

£20000 - £25000 per annum + OTE £45,000: SThree: SThree Group have been well e...

Ashdown Group: IT Manager / Development Manager - NW London - £58k + 15% bonus

£50000 - £667000 per annum + excellent benefits : Ashdown Group: IT Manager / ...

Recruitment Genius: Sales Consultant / Telemarketer - OTE £20,000

£13000 - £20000 per annum: Recruitment Genius: Scotland's leading life insuran...

Ashdown Group: Training Programme Manager - City, London

£40000 - £45000 per annum + benefits : Ashdown Group: Training Programme Manag...

Day In a Page

NHS struggling to monitor the safety and efficacy of its services outsourced to private providers

Who's monitoring the outsourced NHS services?

A report finds that private firms are not being properly assessed for their quality of care
Zac Goldsmith: 'I'll trigger a by-election over Heathrow'

Zac Goldsmith: 'I'll trigger a by-election over Heathrow'

The Tory MP said he did not want to stand again unless his party's manifesto ruled out a third runway. But he's doing so. Watch this space
How do Greek voters feel about Syriza's backtracking on its anti-austerity pledge?

How do Greeks feel about Syriza?

Five voters from different backgrounds tell us what they expect from Syriza's charismatic leader Alexis Tsipras
From Iraq to Libya and Syria: The wars that come back to haunt us

The wars that come back to haunt us

David Cameron should not escape blame for his role in conflicts that are still raging, argues Patrick Cockburn
Sam Baker and Lauren Laverne: Too busy to surf? Head to The Pool

Too busy to surf? Head to The Pool

A new website is trying to declutter the internet to help busy women. Holly Williams meets the founders
Heston Blumenthal to cook up a spice odyssey for British astronaut manning the International Space Station

UK's Major Tum to blast off on a spice odyssey

Nothing but the best for British astronaut as chef Heston Blumenthal cooks up his rations
John Harrison's 'longitude' clock sets new record - 300 years on

‘Longitude’ clock sets new record - 300 years on

Greenwich horologists celebrate as it keeps to within a second of real time over a 100-day test
Fears in the US of being outgunned in the vital propaganda wars by Russia, China - and even Isis - have prompted a rethink on overseas broadcasters

Let the propaganda wars begin - again

'Accurate, objective, comprehensive': that was Voice of America's creed, but now its masters want it to promote US policy, reports Rupert Cornwell
Why Japan's incredible long-distance runners will never win the London Marathon

Japan's incredible long-distance runners

Every year, Japanese long-distance runners post some of the world's fastest times – yet, come next weekend, not a single elite competitor from the country will be at the London Marathon
Why does Tom Drury remain the greatest writer you've never heard of?

Tom Drury: The quiet American

His debut was considered one of the finest novels of the past 50 years, and he is every bit the equal of his contemporaries, Jonathan Franzen, Dave Eggers and David Foster Wallace
You should judge a person by how they peel a potato

You should judge a person by how they peel a potato

Dave Hax's domestic tips are reminiscent of George Orwell's tea routine. The world might need revolution, but we like to sweat the small stuff, says DJ Taylor
Beige is back: The drab car colours of the 1970s are proving popular again

Beige to the future

Flares and flounce are back on catwalks but a revival in ’70s car paintjobs was a stack-heeled step too far – until now
Bill Granger recipes: Our chef's dishes highlight the delicate essence of fresh cheeses

Bill Granger cooks with fresh cheeses

More delicate on the palate, milder, fresh cheeses can also be kinder to the waistline
Aston Villa vs Liverpool: 'This FA Cup run has been wonderful,' says veteran Shay Given

Shay Given: 'This FA Cup run has been wonderful'

The Villa keeper has been overlooked for a long time and has unhappy memories of the national stadium – but he is savouring his chance to play at Wembley
Timeless drama of Championship race in league of its own - Michael Calvin

Michael Calvin's Last Word

Timeless drama of Championship race in league of its own